Πλοήγηση ανά Θέμα "Systemic sclerosis"
Αποτελέσματα 1-6 από 6
-
Autoantibodies in patients with systemic sclerosis and cancer: A case-control study
(2003)Objective. To determine the prevalence of specific autoantibodies in a cohort of patients with systemic sclerosis (SSc) and a diagnosis of cancer, and to compare it to that in a group of patients with SSc who were never ... -
Incident Atrial Fibrillation in Systemic Sclerosis: The Predictive Role of B-Type Natriuretic Peptide
(2014)Introduction: Atrial fibrillation (AF) is common in patients with systemic sclerosis (SSc) and is associated with significant morbidity, mortality, and healthcare expenditures. The aim of this study was to prospectively ... -
Intravenous immunoglobulins (IVIG) in systemic sclerosis: a challenging yet promising future
(2015)The etiology and pathogenesis of systemic sclerosis are still largely unknown, but a variety of humoral and cellular autoimmune phenomena have been documented. In addition, the rarity of the disease, the broad spectrum of ... -
Mycophenolate mofetil in systemic sclerosis-associated interstitial lung disease
(2010)This study aimed to assess the effect of mofetil mycophenolate (MMF), an inhibitor of lymphocyte proliferation, on lung function and skin in patients with systemic sclerosis (SSc)-associated interstitial lung disease ... -
Systemic sclerosis: From pathogenesis towards targeted immunotherapies
(2012)Systemic sclerosis (SSc), a chronic disease with widespread collagen deposition, has three pathogenetic facets: immune activation, microvasculopathy and fibroblast activation. Immune activation and microvasculopathy occur ... -
T-cells and B-cells in systemic sclerosis
(2010)Systemic sclerosis (SSc) is characterized by activation of fibroblasts with extensive deposition of collagen, by small vessel vasculopathy with fibrointimal proliferation, and activation of the immune system, with hyper-γ- ...